Zulma Ferreira

Dr. Zulma Ferreira

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Cell Stem Cell
Verified
Journal Article
Closed access
KGKarin Golan
Karin Golan
AKAnju Kumari
Anju Kumari
OKOrit Kollet
Orit Kollet
EKEman Khatib-Massalha
Eman Khatib-Massalha
MSMohana Devi Subramaniam
Mohana Devi Subramaniam
TLTsvee Lapidot
Tsvee Lapidot

1 September 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
FCFernanda M. Cunha
Fernanda M. Cunha
DBDenise A. Berti
Denise A. Berti
ZFZulma Ferreira
Zulma Ferreira
CKClécio F. Klitzke
Clécio F. Klitzke
RMRegina P Markus
Regina P Markus
EFEmer Ferro
Emer Ferro
Protein degradation by the ubiquitin proteasome system releases large amounts of oligopeptides within cells. To investigate possible functions for these intracellularly generated oligopeptides, we fused them to a cationic transactivator peptide sequence using reversible disulfide bonds, introduced them into cells, and analyzed their effect on G protein-coupled receptor (GPCR) signal transduction. A mixture containing four of these peptides (20-80 microm) significantly inhibited the increase in the extracellular acidification response triggered by angiotensin II (ang II) in CHO-S cells transfected with the ang II type 1 receptor (AT1R-CHO-S). Subsequently, either alone or in a mixture, these peptides increased luciferase gene transcription in AT1R CHO-S cells stimulated with ang II and in HEK293 cells treated with isoproterenol. These peptides without transactivator failed to affect GPCR cellular responses. All four functional peptides were shown in vitro to competitively inhibit the degradation of a synthetic substrate by thimet oligopeptidase. Overexpression of thimet oligopeptidase in both CHO-S and HEK293 cells was sufficient to reduce luciferase activation triggered by a specific GPCR agonist. Moreover, using individual peptides as baits in affinity columns, several proteins involved in GPCR signaling were identified, including alpha-adaptin A and dynamin 1. These results suggest that before their complete degradation, intracellular peptides similar to those generated by proteasomes can actively affect cell signaling, probably representing additional bioactive molecules within cells.

1 December 2007 in Neuroimmunomodulation
Verified
Journal Article
Closed access
RMRegina P Markus
Regina P Markus
ZFZulma Ferreira
Zulma Ferreira
PFPedro A Fernandes
Pedro A Fernandes
ECErika Cecon
Erika Cecon
The time course of the innate immunological response involves a pro-inflammatory phase followed by an anti-inflammatory phase. Pro-inflammatory responses serve as a defense against several stressor conditions, and sequential processes that shut down these responses are necessary to avoid exacerbation or the development of chronic diseases. In the present review, we put together recent data that show that the pineal gland is a player in bidirectional control of the inflammatory response. Healthy organisms stay in standby mode, ready to react. The nocturnal melatonin surge impairs the rolling and adherence of leukocytes to endothelial layers, limiting cell migration, and stimulates nocturnal production of IL-2 by T helper lymphocytes, exerting an immunostimulatory effect. Otherwise, the release of TNF-α from activated macrophages suppresses the nocturnal melatonin surge, allowing a full cell migration and inhibiting IL-2 production. In sequence, activated mononuclear and polymorphonuclear cells produce melatonin in a paracrine manner at the site of injury, which scavenges free radicals and collaborates to resolve the inflammatory response. The sequential diminution of TNF-α production is followed by the recovery of the nocturnal melatonin surge and IL-2 production. In summary, the immune-pineal axis, implicated in the sequential involvement of the melatonin produced by the pineal gland and immune-competent cells, is an integral participant of the innate immune response.


10 November 2004 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
ZFZulma Ferreira
Zulma Ferreira
PFPedro A Fernandes
Pedro A Fernandes
DDDanielle Duma
Danielle Duma
JAJamil Assreuy
Jamil Assreuy
MAMaria C. W. Avellar
Maria C. W. Avellar
RMRegina P Markus
Regina P Markus

25 June 2010 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
Sanseray Da Silveira Cruz-MachadoSanseray Da Silveira Cruz-Machado
Sanseray Da Silveira Cruz-Machado
CCClaudia Emanuele Carvalho‐Sousa
Claudia Emanuele Carvalho‐Sousa
ETEduardo Tamura
Eduardo Tamura
LPLuciana Pinato
Luciana Pinato
ECErika Cecon
Erika Cecon
RMRegina P Markus
Regina P Markus